Meytal Landau, | 2022

Structural Mimicry in Microbial and Antimicrobial Amyloids Connected to Neurodegenerative Diseases

Liisa Galea, Annie Ciernia, | 2022

Combined Hormone Therapy as a Novel Treatment for Alzheimer’s Disease in the Face of a Metabolic Challenge: Influence of Sex and Genotype

Marc Diamond, | 2022

Alzheimer’s Disease Tau Consortium: Role of VCP/p97 in Tau Prion Replication

Katherine Sadleir, Robert Vassar, | 2022

Alzheimer’s Disease Tau Consortium: The Role of Amyloid Beta-Induced Membrane Damage in Tau Pathology

Bradley Hyman, | 2022

Alzheimer’s Disease Tau Consortium: How Do Soluble Tau Species Replicate

Karen Duff, | 2022

Alzheimer’s Disease Tau Consortium: Impact of Tau Mutations and Amyloid Beta on Tau Post-Translational Modifications and Conformation

Marc Diamond, | 2022

RNA as a Determinant of Tau Seeding

Henrik Zetterberg, Gunnar Brinkmalm, | 2022

Deep Mass Spectrometry Profiling of Tau Aggregates in Alzheimer’s Disease and Other Tauopathies

Wilma Wasco, | 2022

Genes to Therapies (G2T), Alzheimer’s Disease Drug Discovery & Development (AD4) and General Scientific Support

Saul Villeda, | 2022

Role of the Circulating Exerkine GPLD1 in Ameliorating Alzheimer’s Disease Pathology

John Hardy, | 2022

Using Long-Read Sequencing to Investigate the MAPT Locus and Transcripts in Neurodegeneration

Srdjan D. Antic, Riqiang Yan, | 2022

Alzheimer’s Disease Pathophysiology Alters the Level of Electrical and Chemical Synapse Coupling in the Network of GABAergic PV+ Interneurons Early in Disease Course